AAH reaches milestone of delivering over 70 million COVID-19 vaccines across England

Date:

Share post:

AAH Pharmaceuticals Ltd (AAH) has exceeded the milestone of delivering over 70 million COVID-19 vaccination doses across England, since it was awarded a contract in December 2020.

In addition, AAH has delivered over 100 million ancillary items to more than 3,000 healthcare providers.

David Bound, chief executive officer of AAH, said: “This is a huge milestone for AAH as we work tirelessly to support our communities. It’s also a ringing endorsement of our delivery drivers, warehouse operatives, and specialist logistics teams and the determination, dedication, and passion they continue to show throughout this extraordinary period.”

The vaccination programme was also recognized by the Supply Chain Excellence Awards.

Chris Emmott, senior project lead – Supply Chain, commented: “I’m incredibly proud that AAH was chosen for this job, particularly as we had the skills, the experience, and a great team to help facilitate the needs of the country. To get ready for a project like this, everybody’s worked very long hours, they’ve worked weekends to get everything ready.

“There’s been huge changes that we’ve had to make to the branch to facilitate the operational needs of delivering this product. We’ve spent a lot of time testing our own operational preparedness and we’ve managed to do that very successfully. We’ve had huge support from the branch, we’ve had fantastic support from our colleagues within AAH, and we’ve had great support from the NHS.”

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Current Issue June 2023

Related articles

MHRA grants authorisation for LEO Pharma’s Adtralza 2 mL pen solution

The Medicines and Healthcare Products Regulatory Agency (MHRA) has approved the marketing authorisation of Adtralza, a dermatological solution...

Grundon launches maiden UK-wide inhaler recycling programme

Grundon Waste Management has introduced what it claims to be the UK's first verified nationwide inhaler return and...

‘Record fine imposed on hydrocortisone manufacturers for dominant position abuse and 10,000% price increase’

The Competition Appeal Tribunal (CAT) has upheld the Competition and Markets Authority’s (CMA) findings against two pharmaceutical manufacturers...

Vision Report: Legal reforms, adequate funding imperative for success of community pharmacy

Achieving the community pharmacy vision necessitates legal adjustments and additional funding beyond recent boosts, the pharmacy vision document...